Chittorgarh.com Logo
Loading...

Par Drugs IPO Details

Issue Open May 3, 2019
Issue Close May 8, 2019
IPO Price ₹51
Face Value ₹10
IPO Size ₹8.53 Cr
Listing At NSE SME
IPO Lot Size 2000
  1. Ven­tyx sprints to Wall Street less than a year af­ter emerg­ing from stealth

    Thu, 21 Oct 2021 04:11:00 GMT

    Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. It took seven months from exiting “quiet mode” for Ventyx Biosciences to land its very own stock ...

  2. Deal Watch: 15 SPACs, 17 IPOs as Dealmakers Continue Historic Run

    Mon, 11 Oct 2021 12:39:00 GMT

    Vaxxinity Inc., a clinical-stage biotech company focused on developing drugs for brain disorders, registered with the SEC on Oct. 8 to list its shares on the Nasdaq. The size of the IPO has not ...

  3. Qim­ing-backed Ab­bisko makes $200M+ Hong Kong de­but, as a SPAC and Agenus spin­out al­so price on Nas­daq

    Fri, 15 Oct 2021 07:10:00 GMT

    Three new entities priced their public debuts late Thursday and early Friday, including a SPAC, a traditional Nasdaq IPO and a Chinese biotech joining the Hong Kong Index. Shanghai-based Abbisko ...

  4. Once-hot SPAC investments return to earth

    Thu, 23 Sep 2021 06:06:00 GMT

    If the SPAC can’t find a company to buy within the timeframe detailed in its IPO, that cash gets returned ... SPACs were recently trading below their par value, according to Goldman Sachs.

  5. NhTherAguix: NH TherAguix announces the launch of its IPO on the Euronext Growth market in Paris

    Tue, 28 Sep 2021 00:52:00 GMT

    DJ NhTherAguix: NH TherAguix announces the launch of its IPO on the Euronext Growth market ... "NH TherAguix aims to demonstrate that its candidate drug AGuIX(R) increases the effectiveness ...

  6. The Beauty Health Company Reminds Investors of Redemption of Public Warrants

    Tue, 19 Oct 2021 13:02:00 GMT

    Warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO and that are still held by the initial holders thereof or their ...

  7. Nykaa, Adani Wilmar, Star Health, 3 others get Sebis go-ahead to float IPOs

    Mon, 18 Oct 2021 01:41:00 GMT

    These six companies, which filed their preliminary IPO papers with Sebi between May and August, obtained its "observations" during October 11-14, an update with Sebi showed on Monday. In Sebi ...

  8. Darktrace stock slumps as early investors sell shares of £187m

    Fri, 01 Oct 2021 08:51:00 GMT

    The company’s initial public offering (IPO) valued it at £1.7bn ($2.3bn), which equated to 250p a share. Shares in the business were down 3.4% Friday evening as markets neared closing, at 792p. The ...

  9. Aditya Birla Sun Life AMC IPO Share Allotment Status Date, Direct Link, GMP, Refund

    Mon, 04 Oct 2021 20:25:00 GMT

    However, the GMP is at par with the listing price. At the upper price band of Rs 712, Aditya Birla Sun Life AMC IPO is available at P/E of 39x (FY21) which appears reasonably priced. Most analysts ...

  10. WeWork back to Wall Street, two years after fiasco

    Tue, 19 Oct 2021 18:52:00 GMT

    WeWork's financial woes and aborted IPO made headlines in 2019, but two years later the office-sharing giant is returning to Wall Street after seeking to renew itself in response to the pandemic.

  11. Villar: IPO shows resilience of AllDay

    Thu, 30 Sep 2021 06:21:00 GMT

    Villar Jr. on Thursday said the approval of regulators for the initial public offering (IPO) of supermarket operator ... Both will have a par value of P0.10 and will be sold at an indicative ...

  12. Forget Facebook: Invest in These Social Media Platforms Instead

    Sat, 16 Oct 2021 05:00:00 GMT

    Since its IPO, shares of social media giant Facebook (NASDAQ:FB) have gained close to 750%. Comparatively, the S&P 500 Index has returned less than 300% in this period. Facebook has become a ...

Par Drugs IPO Alerts

1. Par Drugs IPO Allotment Status  Tuesday, May 14, 2019 12:44:15 AM

The allotment status of Par Drugs and Chemicals Limited IPO is now available online. The public issue of Par Drugs IPO was open on May 3, 2019 and closed for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

2. Par Drugs IPO Listing Date & Info  Monday, May 13, 2019 11:18:15 PM

The IPO Shares of Par Drugs and Chemicals Limited IPO are proposed to list on Thursday, May 16, 2019 at NSE SME. The public issue of Par Drugs IPO was opened on May 3, 2019 and closed for subscription on May 8, 2019. Par Drugs IPO Listing Date and Information:

  • Listing Date: Thursday, May 16, 2019
  • BSE Script Code:
  • NSE Symbol: PAR
  • Listing In:
  • ISIN:
  • Issue Price: 51
  • Face Value: Rs 10 Per Equity Share

3. par drugs ipo Opens on May 3, 2019  Friday, April 26, 2019 10:48:34 AM

Par Drugs and Chemicals Limited is entering in the capital market with an IPO of 1,700,000 Equity Shares of Rs 10 aggregating up to Rs 8.53 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules which are in great demand in the market.

The issue opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.

4. par drugs ipo Closes on May 8, 2019  Friday, April 26, 2019 10:48:34 AM

The issue of Par Drugs and Chemicals Limited opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

Par Drugs IPO News & Events FAQs

The Par Drugs IPO is proposed to open on May 3, 2019. The IPO application ends on May 8, 2019.

Retail investors can apply in the retail or non-institutional investor category from May 3, 2019 to May 8, 2019. The Par Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Par Drugs IPO will open for subscription on May 3, 2019. The public issue will close on May 8, 2019.